Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolism in a 3D in vitro model of the human liver
Open Access
- 10 May 2024
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 397, 111046
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Combinatorial pathway disruption is a powerful approach to delineate metabolic impacts of endocrine disruptorsFEBS Letters, 2022
- High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liabilityArchives of Toxicology, 2019
- Differential capability of metabolic substrates to promote hepatocellular lipid accumulationEuropean Journal of Nutrition, 2018
- Concentrations of cylindrospermopsin toxin in water and tilapia fish of tropical fishponds in Egypt, and assessing their potential risk to human healthEnvironmental Science and Pollution Research, 2018
- Dietaryl‐carnitine prevents histopathological changes in tilapia (Oreochromis Niloticus) exposed to cylindrospermopsinEnvironmental Toxicology, 2015
- Genotoxic effects of the cyanobacterial hepatotoxin cylindrospermopsin in the HepG2 cell lineArchives of Toxicology, 2011
- Toxicity and recovery in the pregnant mouse after gestational exposure to the cyanobacterial toxin, cylindrospermopsinJournal of Applied Toxicology, 2010
- Oral toxicity of the cyanobacterial toxin cylindrospermopsin in male Swiss albino mice: Determination of no observed adverse effect level for deriving a drinking water guideline valueEnvironmental Toxicology, 2003
- Distribution of 14C cylindrospermopsin in vivo in the mouseEnvironmental Toxicology, 2001
- The relation of rat liver wet weight to dry weightHistochemistry and Cell Biology, 1985